Aytu Biopharma Inc (AYTU) Stock Price, Quote & News

Company Profile

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 720 437 6580

Website: aytubio.com

Address:

Denver Corporate Center III, Suite 920 7900 East Union Avenue, Denver, United States

Henry20feb_ Dec. 24 at 8:36 AM

$AYTU

0 · Reply

Alain_Simard Dec. 24 at 1:16 AM

$AYTU bye bye Santa lol

0 · Reply

Love_To_Learn Dec. 22 at 8:18 PM

$PALI ACTIVATING $BIOCQ IN YOUR VAULT! OLD BELOVED $PSTV ACTIVATION $SNCA TRANSFER OF 2.06/2.07 BULLET IN CHAMBER WILL INVOLVE AND INCLUDE $AYTU 1.80 ORIGINAL KEY HOLDER

1 · Reply

Love_To_Learn Dec. 22 at 12:55 PM

$AYTU $SXTP $SIDU THE WHOLE MARKET WILL B IN SIM MODE SO NO REAL TRADING *

0 · Reply

Love_To_Learn Dec. 22 at 9:57 AM

$AYTU $SXTP $SIDU HI

0 · Reply

Doozio Dec. 19 at 6:59 PM

$AYTU Santa is coming?

1 · Reply

Alain_Simard Dec. 19 at 5:51 PM

$AYTU Disbrow is driving the price higher so he doesn’t have a 1000 angry people ready to curse him out at the investor conference

0 · Reply

Alain_Simard Dec. 18 at 5:44 PM

$AYTU whew I was worried that $AYTU was broken yesterday

0 · Reply

ACCESSWIRE Dec. 18 at 3:04 PM

$AYTU Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City

0 · Reply

Fibonacci5 Dec. 18 at 1:08 AM

$AYTU

0 · Reply

Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City

Dec 15, 2025, 9:00 AM EST - 9 days ago

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

Nov 24, 2025, 4:05 PM EST - 4 weeks ago

Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference

Nov 13, 2025, 9:21 PM EST - 5 weeks ago

Aytu BioPharma, Inc. (AYTU) Q1 2026 Earnings Call Transcript

Nov 13, 2025, 4:05 PM EST - 5 weeks ago

Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results

Nov 5, 2025, 4:05 PM EST - 7 weeks ago

Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025

Oct 28, 2025, 9:00 AM EDT - 2 months ago

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

Oct 10, 2025, 9:00 AM EDT - 2 months ago

Aytu BioPharma to Present at Upcoming October 2025 Conferences

Sep 24, 2025, 4:15 PM EDT - 3 months ago

Aytu BioPharma to Present at Upcoming September 2025 Conferences

Sep 23, 2025, 9:43 PM EDT - 3 months ago

Aytu BioPharma, Inc. (AYTU) Q4 2025 Earnings Call Transcript

Sep 23, 2025, 4:05 PM EDT - 3 months ago

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

Sep 16, 2025, 4:05 PM EDT - 3 months ago

Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025

Jun 25, 2025, 8:00 AM EDT - 6 months ago

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

Jun 23, 2025, 8:00 AM EDT - 6 months ago

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

Jun 9, 2025, 4:30 PM EDT - 7 months ago

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Jun 6, 2025, 8:01 AM EDT - 7 months ago

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

Jun 6, 2025, 8:00 AM EDT - 7 months ago

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

May 14, 2025, 8:29 PM EDT - 8 months ago

Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 8 months ago

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

May 7, 2025, 4:15 PM EDT - 8 months ago

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

Apr 21, 2025, 4:05 PM EDT - 8 months ago

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Feb 12, 2025, 6:27 PM EST - 11 months ago

Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript

Feb 12, 2025, 4:03 PM EST - 11 months ago

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Feb 5, 2025, 5:50 PM EST - 11 months ago

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

Jan 6, 2025, 9:00 AM EST - 1 year ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Dec 3, 2024, 11:45 PM EST - 1 year ago

Aytu BioPharma Disclosure Notification

Nov 22, 2024, 9:00 AM EST - 1 year ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Nov 13, 2024, 7:25 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Nov 6, 2024, 5:20 PM EST - 1 year ago

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Oct 14, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 1, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Sep 26, 2024, 6:51 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Sep 26, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Sep 19, 2024, 5:30 PM EDT - 1 year ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Aug 8, 2024, 5:20 PM EDT - 1 year ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Jun 18, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

May 15, 2024, 8:28 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

May 15, 2024, 4:05 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

May 8, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Apr 3, 2024, 9:00 AM EDT - 1 year ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Feb 14, 2024, 10:52 PM EST - 2 years ago

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Feb 14, 2024, 4:05 PM EST - 2 years ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Feb 7, 2024, 4:15 PM EST - 2 years ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Jan 23, 2024, 9:00 AM EST - 2 years ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Nov 30, 2023, 8:00 AM EST - 2 years ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Nov 14, 2023, 7:30 PM EST - 2 years ago

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Nov 14, 2023, 4:05 PM EST - 2 years ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 8, 2023, 8:30 AM EST - 2 years ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Henry20feb_ Dec. 24 at 8:36 AM

$AYTU

0 · Reply

Alain_Simard Dec. 24 at 1:16 AM

$AYTU bye bye Santa lol

0 · Reply

Love_To_Learn Dec. 22 at 8:18 PM

$PALI ACTIVATING $BIOCQ IN YOUR VAULT! OLD BELOVED $PSTV ACTIVATION $SNCA TRANSFER OF 2.06/2.07 BULLET IN CHAMBER WILL INVOLVE AND INCLUDE $AYTU 1.80 ORIGINAL KEY HOLDER

1 · Reply

Love_To_Learn Dec. 22 at 12:55 PM

$AYTU $SXTP $SIDU THE WHOLE MARKET WILL B IN SIM MODE SO NO REAL TRADING *

0 · Reply

Love_To_Learn Dec. 22 at 9:57 AM

$AYTU $SXTP $SIDU HI

0 · Reply

Doozio Dec. 19 at 6:59 PM

$AYTU Santa is coming?

1 · Reply

Alain_Simard Dec. 19 at 5:51 PM

$AYTU Disbrow is driving the price higher so he doesn’t have a 1000 angry people ready to curse him out at the investor conference

0 · Reply

Alain_Simard Dec. 18 at 5:44 PM

$AYTU whew I was worried that $AYTU was broken yesterday

0 · Reply

ACCESSWIRE Dec. 18 at 3:04 PM

$AYTU Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City

0 · Reply

Fibonacci5 Dec. 18 at 1:08 AM

$AYTU

0 · Reply

www_larval_com Dec. 17 at 8:52 PM

$LHAI 14%[-28%] $PCSA 14%[122%] $MENS -6%[-81%] $MGRT -6%[139%] $AYTU 3%[10%] most notable movement into the final minutes of trading.

1 · Reply

Encept Dec. 17 at 4:08 PM

$AYTU is today the day for A2?

2 · Reply

Fffrre321 Dec. 17 at 3:29 PM

$AYTU Where's the black woman who was laughing at Aytu? We're going to be rich except you who had a failed life lol

0 · Reply

Lucky72 Dec. 17 at 3:20 PM

$AYTU RONCO PLAY

0 · Reply

Bangra Dec. 17 at 10:50 AM

$AYTU

0 · Reply

Lucky72 Dec. 16 at 6:26 PM

$AYTU Over Forty thousand watchers,Very quiet .I think I am early.

2 · Reply

Henry20feb_ Dec. 16 at 2:02 PM

$AYTU Inverse Head- and Shoulders Pattern. Wait for confirmation!

0 · Reply

WaspofWallStreet Dec. 15 at 3:52 PM

$AYTU wow. Got a few lots left @ 2.52 I was going to use for tax purposes. What gives.

0 · Reply

DARKP00L Dec. 15 at 2:26 PM

$AYTU 09:03 on Dec. 15 2025 Aytu BioPharma Highlights Commercial Availability Of EXXUA Extended-Release Tablets #tradeideas

0 · Reply

Lucky72 Dec. 15 at 2:03 PM

$AYTU 👍

0 · Reply

Stock_Catcher Dec. 15 at 2:00 PM

$AYTU Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

0 · Reply

Love_To_Learn Dec. 15 at 1:17 PM

$AYTU $SXTP $SIDU will require all 3 of u and more to support beud indirectly she requires further assistance without shifting or bringing in other key stocks and or keys themselves

0 · Reply

Market Cap	25.88M
Revenue (ttm)	66.38M
Net Income (ttm)	-13.56M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-20.43%
Debt to Equity Ratio	1.17

Volume	55,300
Avg Vol	79,396
Day's Range	N/A - N/A
Shares Out	10.19M
Stochastic %K	64%
Beta	0.28
Analysts	Strong Sell
Price Target	$9.33